Inspire Medical Systems, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +8.9%
EBITDA: -18.6%
EBIT: +3.0%
EPS: +103.1%
Free cash flow: +22.7%
Operating cash flow: +19.0%

Forward estimates

Revenue: +10.9%
EBITDA: +309.9%
EPS: -41.9%

Three-year CAGR

Revenue: +30.8%
EBITDA: +22.7%
EBIT: +41.2%
Net income: +171.8%
EPS: +175.0%
Free cash flow: +216.6%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.